Inve India ▾
VIVIJAYA

Vijaya Diagnostic Centre Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 7 Aug 2026

Vijaya Diagnostic Centre Limited reported a strong Q1 FY27, with consolidated revenue growing 22.8% year-on-year to ₹231 crores, driven by a 16.5% increase in test volumes. Profitability saw significant improvement, with EBITDA rising 34% to ₹98 crores and margins expanding by 360 basis points to 42.7%. The company continued its network expansion, commissioning two new hub centres and six spokes, and outlined a capex plan of ₹190-195 crores for further growth, maintaining a strong balance sheet.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q1 FY27: revenue up 22.9%, net profit up 35.9% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue183 169 173 188 202 +10%205 +21%219 +27%231 +23%
EBITDA76 67 69 74 82 +8%86 +28%96 +39%99 +34%
Net profit42 35 35 39 43 +2%43 +23%48 +37%53 +36%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.